Allison Florance

2.8k citations
30 papers · 2.1k · 1 hit paper · h-index 16

Impact in

  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Peptidase Inhibition and Analysis
    • Breast Cancer Treatment Studies

Papers in

Allison Florance

29 papers receiving 2.0k citations

Allison Florance's Hit Papers

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer 2009 · 768 citations
7680+5+11Years since publication250500750

Peers

Allison Florance
Comparison fields: 5 of 92
  • Oncology 1.2k
  • Cancer Research 312
  • Pulmonary and Respiratory Medicine 586
  • Radiology, Nuclear Medicine and Imaging 378
  • Critical Care and Intensive Care Medicine 75
Replace Ingo Schmidt‐Wolf with:
Ingo Schmidt‐Wolf Germany
Peter Buggisch Germany
Pablo J. Cagnoni United States
William L. Read United States
David Loesch United States
Joseph P. Connor United States
Jean‐Pierre Marie France
John M. Lukeman United States
Rex Yung United States
Jean‐Christophe Vaillant France
Allison Florance relative to Ingo Schmidt‐Wolf Germany Ingo Schmidt‐Wolf's profile →
Citations per field
00.5×9.4×
Ingo Schmidt‐Wolf · 1×
Citations per year

Countries citing papers authored by Allison Florance

Since Specialization
Citations

This map shows the geographic impact of Allison Florance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Florance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Florance more than expected).

Fields of papers citing papers by Allison Florance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Florance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Florance. The network helps show where Allison Florance may publish in the future.

Co-authors

The 25 scholars most cited alongside Allison Florance, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Allison Florance Line = papers co-authored together Allison Florance links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
Hit paper breakdown →
2009768
2 2012411
3 1999206
4 2010158
5 2008109
6 199686
7 200949
8 201349
9 201137
10 200532
11 199627
12 201320
13 201519
14 200916
15 200516
16 201315
17 201013
18 200912
19 20057
20 20095

About Allison Florance

Allison Florance is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases, Genetics and Cancer Research, having authored 30 papers that have together received 2.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (14 papers), Cancer Treatment and Pharmacology (13 papers), Advanced Breast Cancer Therapies (12 papers), HIV/AIDS drug development and treatment (4 papers), Estrogen and related hormone effects (3 papers), Breast Cancer Treatment Studies (3 papers), Galectins and Cancer Biology (2 papers) and Brucella: diagnosis, epidemiology, treatment (2 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (312 citations), Pulmonary and Respiratory Medicine (586 citations), Radiology, Nuclear Medicine and Imaging (378 citations) and Critical Care and Intensive Care Medicine (75 citations). Allison Florance has collaborated with scholars based in United States, United Kingdom and Peru. Frequent co-authors include Lisa O’Rourke, Stephen Johnston, J. Maltzman, John Pippen, Michael F. Press, Xavier Pivot, Henry Gómez, Mark D. Pegram, Steven Stein and Alexey Manikhas. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Oncologist, AIDS Research and Human Retroviruses and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact